@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAVc8-4bYcKUpfdzuqZmDMhK6TZhxzBxhjd3DYjmhx--Q> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAVc8-4bYcKUpfdzuqZmDMhK6TZhxzBxhjd3DYjmhx--Q#> .
@prefix beldoc: <http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix schem: <http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-chemicals/> .
@prefix Protein: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080> .
@prefix hgnc: <http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=> .
@prefix geneProductOf: <http://purl.obolibrary.org/obo/RO_0002204> .
@prefix go: <http://amigo.geneontology.org/amigo/term/GO:> .
@prefix obo: <http://purl.obolibrary.org/obo/> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .
sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
  sub:_1 geneProductOf: hgnc:3309 ;
    a Protein: .
  sub:_2 rdf:object go:0008219 ;
    rdf:predicate belv:increases ;
    rdf:subject sub:_1 ;
    a rdf:Statement .
  sub:_3 occursIn: obo:CLO_0001925 , obo:CL_0000066 , obo:UBERON_0003126 , species:9606 ;
    rdf:object sub:_2 ;
    rdf:predicate belv:decreases ;
    rdf:subject schem:Tretinoin ;
    a rdf:Statement .
  sub:assertion rdfs:label "a(SCHEM:Tretinoin) -| (p(HGNC:ELANE) -> bp(GOBP:\"cell death\"))" , "p(HGNC:ELANE) -> bp(GOBP:\"cell death\")" .
}
sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements." ;
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved." ;
    dce:title "BEL Framework Large Corpus Document" ;
    pav:authoredBy sub:_5 ;
    pav:version "20131211" .
  sub:_4 prov:value "Treatment with retinoic acid itself (from 1010 to 106 M) did not alter the viability of BEAS-2B cells (Figure 2A), A549 cells (Figure 2B), or primary cultures of HTE cells (Figure 2C) for 24 h. However, retinoic acid inhibited decreases in cell viability induced by elastase in BEAS-2B cells (0.06 U/ml of elastase) (Figure 2D), A549 cells (0.3 U/ml of elastase) (Figure 2E), and HTE cells (3 U/ml of elastase) (Figure 2F)." ;
    prov:wasQuotedFrom pubmed:12594055 .
  sub:_5 rdfs:label "Selventa" .
  sub:assertion prov:hadPrimarySource pubmed:12594055 ;
    prov:wasDerivedFrom beldoc: , sub:_4 .
}
sub:pubinfo {
  this: dct:created "2014-07-03T14:31:59.105+02:00"^^xsd:dateTime ;
    pav:createdBy orcid:0000-0001-6818-334X , orcid:0000-0002-1267-0234 .
}